Kuehne+Nagel opens new pharma and healthcare control tower in Singapore

3PL company's QuickSTAT site manages cell and gene therapies, vaccine storage, among other roles

QuickSTAT, a subsidiary of the third-party logistics (3PL) provider Kuehne+Nagel, has opened a new control tower and conditioning facility in Singapore. The investment is part of Kuehne+Nagel and QuickSTAT’s pharma and healthcare strategy to further expand their logistics capabilities to serve customers across the Asia Pacific.

This subsidiary helps manage global clinical trial logistics for all phases of the product lifecycle, from research and drug development, to commercialization. The company specializes in time and temperature shipping of clinical research samples, biologics, investigational drugs, clinical trial supplies and vaccines in order to help bring new drugs and medical protocols to market safely and quickly.

The Singapore facility provides various healthcare logistics services for all stages of the pharma product lifecycle. It offers management of cell and gene therapies, and features a controlled-ambient warehouse and in-transit storage for vaccines, investigational drugs, patient clinical specimens and active pharmaceutical ingredient (API).

“We are committed to providing innovative and customized logistics, as well as transportation solutions to meet the ever-challenging demands of the pharma, biotech and life science industry, in all regions of the world. By continuing to expand our global footprint to locations of strategic importance, we are able to provide local and global support for Kuehne+Nagel and QuickSTAT customers,” says Cyril Leger, QuickSTAT’s executive vice president.